|
[1] RINELLA ME. Nonalcoholic fatty liver disease:A systematic review[J]. JAMA,2015,313(22):2263-2273.
|
|
[2] DIEHL AM,DAY C. Cause,pathogenesis,and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med,2017,377(21):2063-2072.
|
|
[3] WEI GC,HE JY. Traditional Chinese medicine intervention to nonalcoholic fatty liver disease based on physique identification[J]. J Changchun Univ Chin Med,2018,34(3):518-521.(in Chinese)魏功昌，何瑾瑜．中医体质辨识治疗非酒精性脂肪性肝病[J]．长春中医药大学学报，2018,34(3):518-521.
|
|
[4] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence,incidence,and outcomes[J]. Hepatology,2016,64(1):73-84.
|
|
[5] ZHU JZ,ZHOU QY,WANG YM,et al. Prevalence of fatty liver disease and the economy in China:A systematic review[J].World J Gastroenterol,2015,21(18):5695-5706.
|
|
[6] WU J,XU H,HE X,et al. Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013[J]. Sci Rep,2017,7:41518.
|
|
[7] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 uptate[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．非酒精性脂肪性肝病防治指南(2018年更新版)[J]．临床肝胆病杂志，2018,34(5):947-957.
|
|
[8] YANG XX,WANG X,DONG JC,et al. The association of mitochondrion and the effect of Chinese medicinal herb in nonalcoholic fatty liver disease[J]. Chin Tradit Patent Med,2018,40(8):1799-1804.(in Chinese)杨兴鑫，王曦，董金材，等．线粒体与非酒精性脂肪性肝病关系及中药对其缓解作用的研究进展[J]．中成药，2018,40(8):1799-1804.
|
|
[9] IPSEN DH,LYKKESFELDT J,TVEDEN-NYBORG P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease[J]. Cell Mol Life Sci,2018,75(18):3313-3327.
|
|
[10] NEUSCHWANDER-TETRI BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis:The central role of nontriglyceride fatty acid metabolites[J]. Hepatology,2010,52(2):774-788.
|
|
[11] LEMASTERS JJ,NIEMINEN AL,QIAN T,et al. The mitochondrial permeability transition in cell death:A common mechanism in necrosis,apoptosis and autophagy[J]. Biochim Biophys Acta,1998,1366(1-2):177-196.
|
|
[12] KOBAYASHI S. Choose delicately and reuse adequately:The newly revealed process of autophagy[J]. Biol Pharm Bull,2015,38(8):1098-1103.
|
|
[13] KIM I,RODRIGUEZ-ENRIQUEZ S,LEMASTERS JJ. Selective degradation of mitochondria by mitophagy[J]. Arch Biochem Biophys,2007,462(2):245-253.
|
|
[14] KLIONSKY DJ,ABDALLA FC,ABELIOVICH H,et al. Guidelines for the use and interpretation of assays for monitoring autophagy[J]. Autophagy,2012,8(4):445-544.
|
|
[15] RODRIGUEZ-ENRIQUEZ S,HE L,LEMASTERS JJ. Role of mitochondrial permeability transition pores in mitochondrial autophagy[J]. Int J Biochem Cell Biol,2004,36(12):2463-2472.
|
|
[16] KIM I,LEMASTERS JJ. Mitochondrial degradation by autophagy(mitophagy)in GFP-LC3 transgenic hepatocytes during nutrient deprivation[J]. Am J Physiol Cell Physiol,2011,300(2):c308-c317.
|
|
[17] XIE R,NGUYEN S,MCKEEHAN WL,et al. Acetylated microtubules are required for fusion of autophagosomes with lysosomes[J]. BMC Cell Biol,2010,11:89.
|
|
[18] WILLIAMS JA,DING WX. A mechanistic review of mitophagy and its role in protection against alcoholic liver disease[J]. Biomolecules,2015,5(4):2619-2642.
|
|
[19] EID N,ITO Y,OTSUKI Y. Triggering of parkin mitochondrial translocation in mitophagy:Implications for liver diseases[J].Front Pharmacol,2016,7:100.
|
|
[20] MEI S,NI HM,MANLEY S,et al. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes[J]. J Pharmacol Exp Ther,2011,339(2):487-498.
|
|
[21] SINGH R,CUERVO AM. Autophagy in the cellular energetic balance[J]. Cell Metab,2011,13(5):495-504.
|
|
[22] SINGH R,KAUSHIK S,WANG YJ,et al. Autophagy regulates lipid metabolism[J]. Nature,2009,458(7242):1131-1135.
|
|
[23] RAUTOU PE,MANSOURI A,LEBREC D,et al. Autophagy in liver diseases[J]. J Hepatol,2010,53(6):1123-1134.
|
|
[24] YIN XM,DING WX,GAO WT. Autophagy in the liver[J].Hepatology,2008,47(5):1773-1785.
|
|
[25] YANG L,LI P,FU S,et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance[J].Cell Metab,2010,11(6):467-478.
|
|
[26] KOGA H,KAUSHIK S,CUERVO AM. Altered lipid content inhibits autophagic vesicular fusion[J]. FASEB J,2010,24(8):3052-3065.
|
|
[27] AMIR M,CZAJA MJ. Autophagy in nonalcoholic steatohepatitis[J]. Expert Rev Gastroenterol Hepatol,2011,5(2):159-166.
|
|
[28] CSAK T,GANZ M,PESPISA J,et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells[J]. Hepatology,2011,54(1):133-144.
|
|
[29] ZHANG Q,RAOOF M,CHEN Y,et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury[J]. Nature,2010,464(7285):104-107.
|
|
[30] KIM MJ,YOON JH,RYU JH. Mitophagy:A balance regulator of NLRP3 inflammasome activation[J]. BMB Rep,2016,49(10):529-535.
|
|
[31] CHI ZC. Pathogenesis of non-alcoholic fatty liver disease[J]. World Chin J Dig,2017,25(8):670-683.(in Chinese)池肇春．非酒精性脂肪性肝病发病机制研究进展与现状[J]．世界华人消化杂志，2017,25(8):670-683.
|
|
[32] YAMAUCHI T,KAMON J,ITO Y,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J]. Nature,2003,423(6941):762-769.
|
|
[33] XU A,WANG Y,KESHAW H,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J]. J Clin Invest,2003,112(1):91-100.
|
|
[34] HARDIE DG. Minireview:The AMP-activated protein kinase cascade:The key sensor of cellular energy status[J]. Endocrinology,2003,144(12):5179-5183.
|
|
[35] LI Z,XU J,ZHENG P,et al. Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway[J]. Int J Clin Exp Med,2015,8(10):17295-17307.
|
|
[36] SLUTSKY N,VATARESCU M,HAIM Y,et al. Decreased adiponectin links elevated adipose tissue autophagy with adipocyte endocrine dysfunction in obesity[J]. Int J Obes(Lond),2016,40(6):912-920.
|
|
[37] GUO R,NAIR S,ZHANG Y,et al. Adiponectin deficiency rescues high-fat diet-induced hepatic injury,apoptosis and autophagy loss despite persistent steatosis[J]. Int J Obes(Lond),2017,41(9):1403-1412.
|
|
[38] EGAN DF,SHACKELFORD DB,MIHAYLOVA MM,et al. Phosphorylation of ULK1(h ATG1)by AMP-activated protein kinase connects energy sensing to mitophagy[J]. Science,2011,331(6016):456-461.
|
|
[39] LIN Z,WU F,LIN S,et al. Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice[J]. J Hepatol,2014,61(4):825-831.
|
|
[40] JIANG P,HUANG Z,ZHAO H,et al. Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease[J]. Biochem Biophys Res Commun,2013,433(4):408-414.
|
|
[41] SZABO G,CSAK T. Inflammasomes in liver disease[J]. J Hepatol,2012,57(37):642-654.
|
|
[42] DOGRU T,ERCIN CN,ERDEM G,et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis[J]. Am J Gastroenterol,2008,103(12):3217-3218.
|
|
[43] ASANUMA T,ONO M,KUBOTA K,et al. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease[J]. Gut,2010,59(2):258-266.
|
DownLoad: